Systemic Medications Associated with Blepharitis, MGD, and Chalazion
A recent study found that some systemic medications may contribute to eyelid conditions like blepharitis, meibomian gland dysfunction (MGD), and chalazion. Using FDA adverse event reports (2003–2024), researchers noted higher rates of MGD in patients taking finasteride, chalazia with bortezomib, and all three conditions with dupilumab. Other drugs, such as isotretinoin and certain cancer therapies, were mainly linked to blepharitis. Most patients affected were middle-aged women, with many cases reported in North America.
The authors stress that while these drugs are important for treating serious illnesses, eye side effects should not be ignored. Clinicians should watch for symptoms, educate patients on eyelid hygiene, and include medication history when diagnosing lid inflammation, even if stopping the medication isn’t an option.
Comments
Post a Comment
Leave a Comment or Question: